Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now?
Evidence has shown that botulinum toxin A has advantages in lower urinary tract dysfunctions (LUTDs), especially in interstitial cystitis, urethral sphincter dysfunction, and inflammatory bladder disorders which currently cannot be adequately treated with oral pharmacological medications. This Speci...
Պահպանված է:
| Ձևաչափ: | Online |
|---|---|
| Լեզու: | անգլերեն |
| Հրապարակվել է: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Խորագրեր: | |
| Առցանց հասանելիություն: | ONIX_20230714_9783036579382_79 |
| Ցուցիչներ: |
Չկան պիտակներ, Եղեք առաջինը, ով նշում է այս գրառումը!
|
| _version_ | 1869526557135994880 |
|---|---|
| collection | Directory of Open Access Books |
| description | Evidence has shown that botulinum toxin A has advantages in lower urinary tract dysfunctions (LUTDs), especially in interstitial cystitis, urethral sphincter dysfunction, and inflammatory bladder disorders which currently cannot be adequately treated with oral pharmacological medications. This Special Issue has collected original or review articles that focus on the novel applications of botulinum toxin A in LUTDs. The research has been updated and contains novel therapeutic applications of botulinum toxin for bladder or urethral dysfunctions. This Special Issue of Toxins provides current knowledge surrounding the status of botulinum toxin in functional urology and LUTDs. |
| format | Online |
| id | doab-20.500.12854ir-101380 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1013802024-03-31T13:09:47Z Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? Kuo, Hann-Chorng adverse events lower-urinary-tract dysfunction therapeutic efficacy urinary incontinence voiding dysfunction botulinum toxin A onabotulinum toxin A bladder pain syndrome/interstitial cystitis long-term treatment bladder pain syndrome interstitial cystitis Sapylin liposome bladder oversensitivity detrusor overactivity interstitial cystitis/bladder pain syndrome botulinum toxin A injection urine biomarkers bladder inflammation botulinum toxin urethral detrusor underactivity urethral sphincter dysfunction dysfunctional voiding poor relaxation of the external sphincter botulinum toxins type A urinary bladder overactive aged postoperative complications spinal cord injury neurogenic bladder onabotulinumtoxinA botox platelet-rich plasma intravesical injection incontinence Parkinson’s disease stroke dyssynergia overactive bladder men lower urinary tract symptoms n/a thema EDItEUR::M Medicine and Nursing Evidence has shown that botulinum toxin A has advantages in lower urinary tract dysfunctions (LUTDs), especially in interstitial cystitis, urethral sphincter dysfunction, and inflammatory bladder disorders which currently cannot be adequately treated with oral pharmacological medications. This Special Issue has collected original or review articles that focus on the novel applications of botulinum toxin A in LUTDs. The research has been updated and contains novel therapeutic applications of botulinum toxin for bladder or urethral dysfunctions. This Special Issue of Toxins provides current knowledge surrounding the status of botulinum toxin in functional urology and LUTDs. 2023-07-14T14:28:44Z 2023-07-14T14:28:44Z 2023 book ONIX_20230714_9783036579382_79 9783036579382 9783036579399 https://directory.doabooks.org/handle/20.500.12854/101380 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/7476 https://mdpi.com/books/pdfview/book/7476 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-7939-9 10.3390/books978-3-0365-7939-9 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036579382 9783036579399 172 Basel open access |
| spellingShingle | adverse events lower-urinary-tract dysfunction therapeutic efficacy urinary incontinence voiding dysfunction botulinum toxin A onabotulinum toxin A bladder pain syndrome/interstitial cystitis long-term treatment bladder pain syndrome interstitial cystitis Sapylin liposome bladder oversensitivity detrusor overactivity interstitial cystitis/bladder pain syndrome botulinum toxin A injection urine biomarkers bladder inflammation botulinum toxin urethral detrusor underactivity urethral sphincter dysfunction dysfunctional voiding poor relaxation of the external sphincter botulinum toxins type A urinary bladder overactive aged postoperative complications spinal cord injury neurogenic bladder onabotulinumtoxinA botox platelet-rich plasma intravesical injection incontinence Parkinson’s disease stroke dyssynergia overactive bladder men lower urinary tract symptoms n/a thema EDItEUR::M Medicine and Nursing Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? |
| title | Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? |
| title_full | Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? |
| title_fullStr | Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? |
| title_full_unstemmed | Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? |
| title_short | Application of Botulinum Neurotoxin in Lower Urinary Tract Dysfunctions: Where Are We Now? |
| title_sort | application of botulinum neurotoxin in lower urinary tract dysfunctions where are we now |
| topic | adverse events lower-urinary-tract dysfunction therapeutic efficacy urinary incontinence voiding dysfunction botulinum toxin A onabotulinum toxin A bladder pain syndrome/interstitial cystitis long-term treatment bladder pain syndrome interstitial cystitis Sapylin liposome bladder oversensitivity detrusor overactivity interstitial cystitis/bladder pain syndrome botulinum toxin A injection urine biomarkers bladder inflammation botulinum toxin urethral detrusor underactivity urethral sphincter dysfunction dysfunctional voiding poor relaxation of the external sphincter botulinum toxins type A urinary bladder overactive aged postoperative complications spinal cord injury neurogenic bladder onabotulinumtoxinA botox platelet-rich plasma intravesical injection incontinence Parkinson’s disease stroke dyssynergia overactive bladder men lower urinary tract symptoms n/a thema EDItEUR::M Medicine and Nursing |
| topic_facet | adverse events lower-urinary-tract dysfunction therapeutic efficacy urinary incontinence voiding dysfunction botulinum toxin A onabotulinum toxin A bladder pain syndrome/interstitial cystitis long-term treatment bladder pain syndrome interstitial cystitis Sapylin liposome bladder oversensitivity detrusor overactivity interstitial cystitis/bladder pain syndrome botulinum toxin A injection urine biomarkers bladder inflammation botulinum toxin urethral detrusor underactivity urethral sphincter dysfunction dysfunctional voiding poor relaxation of the external sphincter botulinum toxins type A urinary bladder overactive aged postoperative complications spinal cord injury neurogenic bladder onabotulinumtoxinA botox platelet-rich plasma intravesical injection incontinence Parkinson’s disease stroke dyssynergia overactive bladder men lower urinary tract symptoms n/a thema EDItEUR::M Medicine and Nursing |
| url | ONIX_20230714_9783036579382_79 |